Vericel (VCEL) Reports Q2 Loss of $0.12/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- SanDisk stock rallies on AI optimism and Fed relief
Vericel Corporation (VCEL) PT Lowered to $14 at Needham & Company, Keeps 'Buy'
August 7, 2018 9:14 AM EDTNeedham & Company lowered its price target on Vericel Corporation (NASDAQ: VCEL) to $14.00 (from $15.00) while maintaining a Buy rating.
Analyst Chad Messer commented, "Vericel reported $19.0M in net product sales including $14.1M in MACI sales and $4.9M for Epicel. Our estimate was... More
